
-
Itoje back as Lions take no chances against ACT Brumbies
-
Stock markets struggle as Trump's tariff deadline looms
-
Nearly 450,000 Afghans left Iran since June 1: IOM
-
North Korea bars Western influencers from trade fair tour
-
Typhoon Danas kills two, injures hundreds in Taiwan
-
Dutch coastal village turns to tech to find lost fishermen
-
Boxer Chavez's appeal against arrest if deported from US rejected: Mexico prosecutor
-
India captain Gill hailed back home after 'brilliant' Test win
-
The making of Australia's mushroom murders
-
Indonesia volcano spews 18-kilometre ash tower
-
Youthful Chelsea ready for Thiago Silva reunion at Club World Cup
-
Australian inquiry cites racism in Indigenous shooting
-
Djokovic wary despite Wimbledon form, dominant Sinner faces Dimitrov
-
Australian woman found guilty of triple murder with toxic mushrooms
-
Indonesia volcano spews 18-kilometre ash tower: agency
-
Trump says to send first tariff letters on Monday
-
The strange case of Evgeniya Mayboroda, Russia's rebel retiree
-
Asian markets drop as Trump's tariff deadline looms
-
Under-strength Brumbies eye 'big opportunity' against Lions
-
Macron to rekindle relationship with Francophile King Charles on UK visit
-
Trump hosts Netanyahu, hopes for Israel-Hamas deal 'this week'
-
Pressed to confess: Japan accused of 'hostage justice'
-
Demna to bow out at Balenciaga in Paris Haute Couture Week
-
Host of internationals in Australia-New Zealand squad to face Lions
-
Egyptian conservators give King Tut's treasures new glow
-
Mexico defeat USA 2-1 to retain CONCACAF Gold Cup
-
Visa's 24/7 war room takes on global cybercriminals
-
BRICS nations slam Trump tariffs, condemn strikes on Iran
-
BioNxt's Sublingual Cladribine Program for MS Ready for Next Phase
-
Guardian Metal Resources PLC Announces Pilot North Tungsten Project Acquired via Staking
-
MLB Nationals fire manager Martinez, GM Rizzo after loss
-
US tariffs to kick in Aug 1, barring trade deals
-
Trump slams former ally Musk's political party as 'ridiculous'
-
Three things we learned from the second England-India Test
-
Norway reach Euro 2025 quarter-finals as Swiss down eliminated Iceland
-
Alcaraz vows to avoid Murray after defeat on golf course
-
Alcaraz finds magic touch at Wimbledon as Sabalenka storms into quarter-finals
-
Run-hungry Gill glad to 'lead by example' as India level England series
-
Rockets confirm arrival of Durant in unprecedented NBA seven-team trade
-
Alcaraz survives Rublev test to stay on course for Wimbledon hat-trick
-
New Zealand's Dixon wins seventh IndyCar Mid-Ohio title
-
US tariffs to kick in Aug 1, barring trade deals: Bessent
-
England consider Archer and Atkinson recall after heavy India defeat
-
Durant deal becomes NBA-record seven-team trade: reports
-
Verstappen laments 'really difficult' Silverstone fifth
-
BRICS nations hit out at Trump tariffs
-
Hansen shoots Norway to brink of Euro 2025 quarter-finals
-
Jennifer Geerlings-Simons becomes Suriname's first woman president
-
Netanyahu says Trump meeting could 'advance' Gaza deal ahead of Doha talks
-
BRICS meeting in Rio hits out at Trump tariffs

Particle physics pushing cancer treatment boundaries
Researchers at Europe's science lab CERN, who regularly use particle physics to challenge our understanding of the universe, are also applying their craft to upend the limits to cancer treatment.
The physicists here are working with giant particle accelerators in search of ways to expand the reach of cancer radiation therapy, and take on hard-to-reach tumours that would otherwise have been fatal.
In one CERN lab, called CLEAR, facility coordinator Roberto Corsini stands next to a large, linear particle accelerator consisting of a 40-metre metal beam with tubes packed in aluminium foil at one end, and a vast array of measurement instruments and protruding colourful wires and cables.
The research here, he told AFP during a recent visit, is aimed at creating very high energy beams of electrons -- the negatively charged particles in the nucleus of an atom -- that eventually could help to combat cancerous cells more effectively.
They are researching a "technology to accelerate electrons to the energies that are needed to treat deep-seated tumours, which is above 100 million electron volts" (MeV), Corsini explained.
The idea is to use these very high energy electrons (VHEE) in combination with a new and promising treatment method called FLASH.
- Reducing 'collateral damage' -
This method entails delivering the radiation dose in a few hundred milliseconds, instead of minutes as is the current approach.
This has been shown to have the same destructive effect on the targeted tumour, but causes far less damage to the surrounding healthy tissue.
With traditional radiation therapy, "you do create some collateral damage," said Benjamin Fisch, a CERN knowledge transfer officer.
The effect of the brief but intense FLASH treatment, he told reporters, is to "reduce the toxicity to healthy tissue while still properly damaging cancer cells."
FLASH was first used on patients in 2018, based on currently available medical linear accelerators, linacs, that provide low-energy electron beams of around 6-10 MeV.
At such low energy though, the beams cannot penetrate deeply, meaning the highly-effective treatment has so far only been used on superficial tumours, found with skin cancer.
But the CERN physicists are now collaborating with the Lausanne University Hospital (CHUV) to build a machine for FLASH delivery that can accelerate electrons to 100 to 200 MeV, making it possible to use the method for much more hard-to-reach tumours.
- 'Game-changer' -
Deep-lying cancer tumours that can't be rooted out using surgery, chemotherapy or traditional radiation therapy are often today considered a death sentence.
"It is the ones which we don't cure at the moment which will be the targets," Professor Jean Bourhis, head of CHUV's radiology department, told AFP.
"For those particular cancers, which may be one third of the cancer cases, it could be a game-changer."
There are particular hopes that the FLASH method, with its far less harmful impact on surrounding tissue, could make it possible to go after tumours lodged in the brain or near other vital organs.
Bourhis said it might not relegate deaths from stubborn cancer tumours to the history books, "but at least there will be a new opportunity for more cures, if it works."
- 'Compact' -
One challenge is making the powerful accelerator compact enough to fit inside a hospital.
At CERN, a large gallery has been dedicated to housing the CLEAR accelerator, which requires 20 metres to push the electrons up to the required energy level -- and another 20 metres to condition, measure and deliver the beam.
But Corsini insisted that CERN had the know-how to "accelerate in a much more compact space".
The prototype being designed with CHUV will aim to do the same job with a machine that is 10 metres overall.
This "compact" solution, Corsini said, "reduces the cost, reduces power consumption and variability, and you can easily put it into a hospital without having to build a whole building."
Construction of the prototype is scheduled to begin next February, and patient clinical trials could begin in 2025, Bourhis said, "if everything goes smoothly".
F.Dubois--AMWN